Introduction
============

Over the past few decades, the prevalence of diabetes in developed and developing countries has risen substantially, making diabetes a key health priority globally.[@ref1] Examination of trends in total burden of diabetes is an essential part of the monitoring of this health priority area, but, to date, it has consisted primarily of studies looking at diabetes prevalence.[@ref1] [@ref2] [@ref3] [@ref4] [@ref5] Prevalence estimates suggest that the diabetes burden is still rising in most countries, and this is often interpreted as evidence of increasing risk in the population. However, selective incidence studies[@ref6] [@ref7] and some accompanying risk factor data[@ref8] suggest otherwise. Prevalence can be a crude and misleading metric of the trajectory of an epidemic, because increasing prevalence of a disease might be due to either increasing incidence or to improved survival. Furthermore, prevalence cannot be reliably used to study the effects of changes in population risk factors, because their effects are detected earlier with incidence trends than with prevalence trends, and incidence is not affected by changes in survival.

Incidence measures the proportion of people who develop diabetes over a period of time among the population at risk. It is the appropriate measure of population risk, and a valuable way of assessing whether public health campaigns for diabetes prevention are succeeding. While prevalence can rise simply because mortality falls, incidence of diagnosed diabetes is affected only by the risk of the population and the amount of screening undertaken. Changes in prevalence might be an inadequate guide to the effects of prevention activities, and could lead to the inappropriate rejection of effective interventions. It is only by measuring both incidence and prevalence that a better understanding of the extent of diabetes can be achieved.

Among existing diabetes incidence data, a few studies suggest that diabetes incidence could be falling despite rising or stable prevalence,[@ref6] [@ref7] [@ref9] but not all data are consistently showing the same trends. For example, studies from England and Wales (1994-98),[@ref10] Portugal (1992-2015),[@ref11] and Canada (1995-2007)[@ref12] are reporting increases in diabetes incidence. To understand what is happening at a global level over time, a systematic approach to review all incidence trend data should be undertaken to study patterns and distributions of incidence trends by time, age, and sex. So far, no systematic reviews have reported on trends in the incidence of diabetes. Therefore, we conducted a systematic review of the literature reporting diabetes incidence trends.

Methods
=======

Data sources and searches
-------------------------

We conducted a systematic review in accordance with PRISMA guidelines.[@ref13] We searched Medline, Embase, and CINAHL from January 1980 to December 2017 without language restrictions. The full search strategy is available in supplementary table 1.

Study selection
---------------

### Inclusion and exclusion criteria

Eligible studies needed to report diabetes incidence in two or more time periods. Study populations derived from open, population based cohort studies (that is, with ongoing recruitment over time), diabetes registries, or administrative or health insurance databases based mainly or wholly in primary care (electronic medical records, health insurance databases, or health maintenance organisations). We also included serial, cross sectional, population based studies where incidence was defined as a person reporting the development of diabetes in the 12 months before the survey. Studies were required to report on the incidence of either total diabetes or type 2 diabetes. We excluded studies reporting incidence restricted to select groups (eg, people with heart failure) and studies reporting only on children or youth.

Each title and abstract was screened by at least two authors (DJM, JES, DNK, JLH, and MT) and discrepancies were resolved by discussion. We aimed to avoid overlap of populations between studies. Therefore, if national data and regional data were available from the same country over the same time period, we only included the national data. If multiple publications used the same data source, over the same time period, we chose the publication that covered the longest time period.

### Outcome measure

Our outcome was diabetes incidence using various methods of diabetes ascertainment including: blood glucose, glycated haemoglobin (HbA1c), linkage to drug treatment or reimbursement registries, clinical diagnosis by physicians, administrative data (ICD codes (international classification of diseases)), or self report. Several studies developed algorithms based on several of these elements to define diabetes. We categorised the definition of diabetes into one of five groups: clinical diagnosis, diabetes treatment, algorithm derived, glycaemia defined (blood glucose or HbA1c, with or without treatment), and self report.

### Data extraction and quality of studies

We extracted crude and standardised incidence by year (including counts and denominators) and the reported pattern of the trends (increasing, decreasing, or stable, (that is, no statistically significant change)) in each time period as well as study and population characteristics. Age specific data were also extracted if available. Data reported only in graphs were extracted by DigitizeIt software (European Organisation for Nuclear Research, Germany). We assessed study quality using a modified Newcastle-Ottawa scale for assessing the risk of bias of cohort studies[@ref14] (supplementary material).

Statistical methods
-------------------

Data were reported as incidence density (per person year) or yearly rates (percentage per year). From every study, we extracted data from every subpopulation reported, such that a study reporting incidence in men and women separately contributed two populations to this analysis. If studies reported two different trends over different time periods, we considered these as two populations. Further, if the study was over 10 years in duration, we treated these as two separate time periods. To avoid double counting, when the data were reported in the total population as well as by sex and ethnic groups, we only included data once and prioritised ethnicity specific data over sex specific data.

We extracted the age specific incidence data reported for every individual calendar year. These data were then categorised into four age bands (\<40, 40-54, 55-69, and ≥70), and were plotted against calendar year. In studies where counts and denominators were reported by smaller age groups than we used, we recalculated incidence across our specified larger age groups. If we found multiple age groups within any of our broader age groups, but with insufficient information to combine the data into a new category, only data from one age group were used. To limit overcrowding on plots, if data were available for men, women, and the total population, only total population data were plotted. Data from populations with high diabetes incidence such as Mauritians[@ref15] and First Nation populations from Canada[@ref16] were plotted separately to allow the examination of most of the data more easily on a common scale (supplementary material). Furthermore, studies reporting data before 1991 or populations with fewer than three data points were not plotted. We also categorised studies into European and non-European populations on the basis of the predominant ethnicity of the population in which they were conducted. Studies conducted in Israel, Canada, and the United States were assigned to the European category.

We took two approaches to analyse trends of diabetes incidence over time. Firstly, we allocated the reported trend (increasing, decreasing, or stable (that is, no statistically significant change)) of each population to the mid-point of each study's observational period, and then assigned this trend into one of five time periods (1960-79, 1980-89, 1990-99, 2000-05, and 2006-14). Where a test of significance of trends was not reported or when a time period was longer than 10 years, we performed Joinpoint trend analyses[@ref17] [@ref18] to observe any significant trends in the data (assuming a constant standard deviation). Joinpoint Trend Analysis Software (version 4.5.0.1) uses permutation tests to identify points where linear trends change significantly in direction or in magnitude, and calculates an annual percentage change for each time period identified. In sensitivity analyses we also tested different cut points in the last two time periods.

The second approach was used to more accurately allocate trends to the prespecified time periods. Among the studies that reported raw counts of diabetes cases and denominators, we examined the association between calendar year and incidence, using Poisson models with the log person years as offset. The midpoints of age and calendar period were used as continuous covariates, and the effects of these were taken as linear functions. We analysed each study separately by prespecified time periods, and reported annual percentage change when the number of data points in the time period was at least four. For studies that did not provide raw data but did report a sufficient number of points, we analysed the relation between year and incidence using Joinpoint regression across the time periods specified above and reported annual percentage change. Analyses were conducted with Stata software version 14.0 (Stata Corporation, College Station, TX, USA), and Joinpoint (Joinpoint Desktop Software Version 4.5.0.1).[@ref17] [@ref18]

Patient and public involvement
------------------------------

No patients or members of the public were involved in setting the research question or the outcome measures for this study. No patients were asked to advise on interpretation or writing up of results. We intend to disseminate this research through press releases and at research meetings.

Results
=======

We found 22 833 unique abstracts from 1 January 1980 to the end of 2017. Among these, 80 described trends of diabetes incidence, of which 47 met all inclusion criteria. Articles describing trends were excluded for the following reasons: duplicated data (n=21), closed cohorts (n=5), populations included youth only (n=1), occupational cohorts (n=2), or no usable data presented (n=4; [fig 1](#f1){ref-type="fig"}).

![Flowchart of study selection](magd049257.f1){#f1}

[Table 1](#tbl1){ref-type="table"} and supplementary material [table 2](#tbl2){ref-type="table"} describe the characteristics of the included studies. Only 19% (9/47) of studies were from predominantly non-Europid populations and 4% (2/47) of studies were from low or middle income countries (China[@ref25] and Mauritius[@ref15]). Administrative datasets, health insurance data, registry data, survey data, and cohort studies accounted for 38% (n=18), 21% (n=10), 19% (n=9), 11% (n=5), and 11% (n=5) of the 47 data sources, respectively. Among the 47 studies, diabetes was defined by a clinical diagnosis, diabetes treatment (via linkage to drug treatment registers), an algorithm, blood glucose, and self report in 28% (n=13), 9% (n=4), 47% (n=22), 11% (n=5), and 6% (n=3) of studies, respectively. Sample sizes of the populations were greater than 10 000 in every year in 85% (n=40) of the studies, and greater than 130 000 per year in 70% (n=33) of the studies. A total of 62% (n=29) of the 47 included studies exclusively reported on type 2 diabetes, and 38% (n=18) reported on total diabetes.

###### 

Characteristics of 47 included studies reporting on diabetes incidence trends, by country

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author, year                      Years reported                                 Country                 Origin of data                                      Type of data       Diabetes definition                  Age range
  --------------------------------- ---------------------------------------------- ----------------------- --------------------------------------------------- ------------------ ------------------------------------ -----------
  CCDSS et al 2017[@ref19]          2000-11                                        Canada                  CCDSS (administrative data)                         Administrative     Administrative algorithm             ≥0

  Dyck et al 2010[@ref16]           1980-2005                                      Canada                  Ministry of Health's insurance registry             Administrative     Administrative algorithm             ≥20

  Oster et al 2011[@ref12]          1995-2007                                      Canada, Alberta         Provincial administrative health records            Administrative     Administrative algorithm             ≥20

  Blanchard et al 1996\*[@ref20]    1986-91                                        Canada, Manitoba        Manitoba Health Insurance, diabetes database        Health insurance   Administrative algorithm             ≥25

  Green et al 2003\*[@ref21]        1989, 1998†                                    Canada, Manitoba        Manitoba Health Insurance, diabetes database        Health insurance   Administrative algorithm             ≥20

  Alangh et al 2013[@ref22]         1996, 2001, 2003, 2005†                        Canada, Ontario         Population health surveys linked to registry        Survey             Clinical diagnosis                   ≥30

  Lipscombe et al 2007[@ref23]      1997-2003                                      Canada, Ontario         Population based diabetes database                  Administrative     Administrative algorithm             ≥20

  Horn et al 2007[@ref24]           1986-2003                                      Canada, Quebec          KHMC diabetes registry                              Registry           Clinical diagnosis                   ≥18

  Liu et al 2007[@ref25]            1999-2005                                      China, Harbin           Administrative health database                      Administrative     Clinical diagnosis                   ≥0

  Carstensen et al 2008\*[@ref26]   1995-2006                                      Denmark                 National diabetes register                          Registry           Administrative algorithm             ≥0\
                                                                                                                                                                                                                       ≥0

  Green et al 2015\*[@ref27]        2000-11                                        Denmark                 National diabetes register                          Registry           Administrative algorithm             

  Abouzeid et al 2015[@ref28]       1970s, 1980s, 1990s†                           Finland                 Finnrisk surveys linked to reimbursement database   Survey             Diabetes treatment                   30-59

  Laakso et al 1991[@ref29]         1970-87                                        Finland                 Medication database                                 Registry           Diabetes treatment                   ≥30

  Michaeli et al 1993[@ref30]       1940-89                                        Germany, East           National diabetes register                          Registry           Clinical diagnosis                   ≥0

  Boehme et al 2015[@ref31]         2007-10                                        Germany, southwestern   Claims data AOK Baden, Wuerttemberg                 Health insurance   Administrative algorithm             ≥0

  Quan et al 2017[@ref32]           2007-14                                        Hong Kong, China        Hospital Authority clinical management system       Administrative     Administrative algorithm             ≥20

  Vilbergsson et al 1997[@ref33]    1968-71, 1972-75, 1976-79, 1980-85†            Iceland, Reykjavik      Reykjavik study                                     Cohort studies     Glucose (FBG, OGTT) plus treatment   34-79

  Karpati et al 2014[@ref34]        2004-12                                        Israel                  Clalit health services                              Health insurance   Administrative algorithm             \>26

  Monesi et al 2011[@ref35]         2000-07                                        Italy,\                 Administrative health database                      Administrative     Administrative algorithm             ≥0
                                                                                   Lombardy                                                                                                                            

  Song et al 2016[@ref36]           2004-12                                        Korea                   Korean national data health insurance               Health insurance   Administrative algorithm             ≥0

  Soderberg et al 2004[@ref15]      1987-92, 1992-98†                              Mauritius               Non communicable disease survey                     Cohort studies     Glucose (FBG, OGTT) plus treatment   20-79

  Dowse et al 1991[@ref37]          1975/76-82, 1982-87†                           Nauru                   Non communicable disease survey                     Survey             Glucose (FBG, OGTT) plus treatment   ≥20

  Ruwaard et al 1996[@ref38]        1980-83, 1990-92†                              Netherlands             Dutch Sentinel Practice network                     Administrative     Clinical diagnosis                   ≥0

  Strom et al 2014[@ref39]          2006-11                                        Norway                  Norwegian prescription database                     Administrative     Diabetes treatment                   ≥0

  de Sousa-Uva et al 2016[@ref11]   1992-2015                                      Portugal                General Practice Sentinel network                   Administrative     Clinical diagnosis                   ≥0

  Evans et al 2007[@ref40]          1993-2004                                      Scotland                DARTS clinical system                               Administrative     Administrative algorithm             \>35

  Read et al 2016[@ref41]           2004-13                                        Scotland                Diabetes register                                   Registry           Clinical diagnosis                   40-89

  Berger et al 1999[@ref42]         1991-95                                        Sweden                  Skaraborg Swedish diabetes registry                 Registry           Clinical diagnosis                   ≥0

  Jansson et al 2015[@ref43]        2006-12                                        Sweden                  Data from national Swedish registers                Registry           Diabetes treatment                   ≥0

  Jansson et al 2007[@ref44]        1972-2001                                      Sweden, Laxa            Diabetes register in primary care network           Administrative     Clinical diagnosis                   ≥0

  Ringborg et al 2008[@ref45]       1996-2003                                      Sweden, Uppsala         RECAP-DM (26 primary healthcare providers)          Administrative     Administrative algorithm             \>30

  Huber et al 2014[@ref46]          2007, 2011†                                    Switzerland             Switzerland healthcare claims data                  Health insurance   Administrative algorithm             ≥19

  Lin et al 2013[@ref47]            2000-07                                        Taiwan                  National insurance research database                Health insurance   Administrative algorithm             ≥20

  Tseng et al 2006[@ref48]          1992-96                                        Taiwan                  National insurance research database                Health insurance   Administrative algorithm             ≥0

  Holden et al 2013\*[@ref49]       1991-2010                                      UK                      Clinical Practice Research Datalink                 Administrative     Clinical diagnosis                   ≥0

  Zghebi et al 2017\*[@ref50]       2004-14                                        UK                      Clinical Practice Research Datalink                 Administrative     Clinical diagnosis                   ≥16

  Abraham et al 2015[@ref8]         1970s, 1980s, 1990s, 2000s†                    US                      FHS, FOS, population based, biennial exams          Cohort study       Glucose (FBG) plus treatment         40-55

  Akushevich et al 2013[@ref51]     1993-2005                                      US                      Seer Medicare NLTCS Medicare                        Administrative     Clinical diagnosis                   \>65

  Burke et al 2002[@ref52]          1970-74, 1975-79, 1990-84, 1985-89, 1990-94†   US                      Rochester epidemiology project                      Administrative     Administrative algorithm             ≥30

  CDC et al 2008[@ref53]            1995-97, 2005-07†                              US                      BFRSS                                               Survey             Self report                          ≥18

  Geiss et al 2014[@ref6]           1980-2012                                      US                      NHIS                                                Survey             Self report                          20-79

  McBean et al 2004[@ref54]         1994-2001                                      US                      Medicare database                                   Administrative     Administrative algorithm             ≥65

  Narayanan et al 2010[@ref55]      1986-90,\                                      US                      Alaska Native diabetes registry                     Registry           Clinical diagnosis                   ≥0
                                    1991-98,\                                                                                                                                                                          
                                    1999-2001,\                                                                                                                                                                        
                                    2001-06†                                                                                                                                                                           

  Nichols et al 2015[@ref56]        2006-11                                        US                      Multicentre consortium SUPREME-DM                   Health insurance   Administrative algorithm             ≥20

  Tabaei et al 2012[@ref57]         2002, 2004, 2008†                              US                      New York Community Health Survey                    Cohort study       Self report                          ≥18

  Weng et al 2016[@ref9]            2007, 2012†                                    US                      Truven Health MarketScan                            Health insurance   Administrative algorithm             ≥18

  Pavkov et al 2007[@ref58]         1965-77, 1978-90, 1991-2003†‡                  US, Pima                Cohort study with biennial exams                    Cohort study       Glucose (FBG, OGTT) plus treatment   ≥5
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

BRFSS=Behavioural Risk Factor Surveillance System; CCDSS=Canadian chronic disease surveillance system; CDC=US Centre for Disease Control and Prevention; DARTS=Diabetes Audit and Research in Tayside Scotland; FBG=fasting blood glucose; FHS=Framingham Heart Study; FOS=Framingham Offspring Study; KMHC=Kateri Memorial Hospital Centre; NHIS=National Health Interview Survey; NLTCS=National Long Term Care Survey; OGTT=oral glucose tolerance test; RECAP-DM= Real-Life Effectiveness and Care Patterns in Diabetes Management; SUPREME- DM=Surveillance, Prevention and Management of Diabetes Mellitus study.

Studies used the same country or region specific data source; authors used the same database but reported incidence for different time periods.

Studies did not measure incidence in continuous years.

Sex specific incidence was not reported in the paper, but described in the text.

###### 

Summary of patterns of diabetes incidence trends based on analyses reported in publications in 1960-99

  First author, year                Years included (range)   Mid-point   Country       Predominant ethnicity        Incidence trends (increasing, stable, or decreasing)              
  --------------------------------- ------------------------ ----------- ------------- ---------------------------- ------------------------------------------------------ ---------- ----------
  **1960-79**                                                                                                                                                                         
  Michaelis et al 1993\*[@ref30]    1960-69                  1965        Germany       Europid                                                                                        Increase
  Michaelis et al 1993\*[@ref30]    1970-79                  1975        Germany       Europid                                                                                        Increase
  Jansson et al 2007[@ref44]        1972-79                  1976        Sweden        Europid                      Stable                                                 Stable     
  Vilbergsson et al 1997[@ref33]    1968-85                  1977        Iceland       Europid                      Stable                                                 Stable     
  Burke et al 2002[@ref52]          1970-82                  1976        US            Europid                      Increase                                               Increase   
  Pavkov et al 2007[@ref58]         1971-84                  1978        US            Non-Europid (Pima)                                                                             Stable
  **1980-89**                                                                                                                                                                         
  Abouzeid et al 2015[@ref28]       1975-85                  1980        Finland       Europid                      Increase                                               Stable     
  Abraham et al 2015[@ref7]         1970-89                  1980        US            Europid                                                                                        Stable
  Dowse et al 1991[@ref37]          1979-85                  1982        Nauru         Non-Europid                                                                                    Stable
  Abraham et al 2015[@ref7]         1970-97                  1984        US            Europid                                                                                        Increase
  Michaelis et al 1993\*[@ref30]    1980-89                  1985        Germany       Europid                                                                                        Stable
  Jansson et al 2007[@ref44]        1980-89                  1985        Sweden        Europid                      Stable                                                 Stable     
  Geiss et al 2014[@ref6]           1980-89                  1985        US            Europid                      Increase                                               Stable     
  Ruwaard et al 1996[@ref38]        1980-92                  1986        Netherlands   Europid                                                                                        Increase
  Blanchard et al 1996[@ref20]      1986-91                  1989        Canada        Europid                      Decrease                                               Decrease   
  **1990-99**                                                                                                                                                                         
  Horn et al 2007†[@ref24]          1986-94                  1990        Canada        Non-Europid (First Nation)                                                                     Decrease
  Abouzeid et al 2015[@ref28]       1985-95                  1990        Finland       Europid                      Increase                                               Stable     
  Burke et al 2002[@ref52]          1987-92                  1990        US            Europid                      Stable                                                 Stable     
  Pavkov et al 2007[@ref58]         1984-97                  1991        US            Non-Europid (Pima)                                                                             Stable
  Soderberg et al 2004[@ref15]      1987-98                  1993        Mauritius     Non -Europid                 Stable                                                 Increase   
  Berger et al 1999[@ref42]         1991-95                  1993        Sweden        Europid                                                                                        Stable
  Tseng et al 2006[@ref48]          1992-96                  1994        Taiwan        Non-Europid (Taiwan)         Increase                                               Increase   
  Jansson et al 2007[@ref44]        1990-99                  1995        Sweden        Europid                      Stable                                                 Stable     
  Holden et al 2013[@ref49]         1991-2000                1995        UK            Europid                      Increase                                               Increase   
  Geiss et al 2014[@ref6]           1990-2000                1995        US            Europid                      Increase                                               Increase   
  Cartensen et al 2008‡[@ref26]     1989-2003                1996        Denmark       Europid                      Increase                                               Increase   
  Narayanan et al 2010[@ref55]      1986-2006                1996        US, Alaska    Non-Europid (Indian)                                                                           Increase
  Narayanan et al 2010[@ref55]      1986-2006                1996        US, Alaska    Non-Europid (Aleut)                                                                            Increase
  Narayanan et al 2010[@ref55]      1986-2006                1996        US, Alaska    Non-Europid (Eskimo)                                                                           Increase
  de Sousa-Uva et al 2016[@ref11]   1992-2003                1998        Portugal      Europid                      Increase                                               Increase   
  McBean et al 2004[@ref54]         1994-2001                1998        US            Europid                                                                                        Increase
  McBean et al 2004[@ref54]         1994-2001                1998        US            Non-Europid (White)                                                                            Increase
  McBean et al 2004[@ref54]         1994-2001                1998        US            Non-Europid (Black)                                                                            Increase
  McBean et al 2004[@ref54]         1994-2001                1998        US            Non-Europid (Hispanic)                                                                         Increase
  Horn et al 2007†[@ref24]          1994-2003                1999        Canada        Non-Europid (First Nation)                                                                     Stable
  Evans et al 2007[@ref40]          1993-2004                1999        UK            Europid                      Increase                                               Increase   
  Akushevich et al 2013[@ref51]     1992-2005                1999        US            Europid                                                                                        Increase

Empty cells in the table imply that the study did not report data through that decade.

First period of data from 1945-60 not included.

Only total population data was used from Horn et al,[@ref24] because sex specific data were based on small numbers.

Data from Denmark were extracted from Carstensen et al[@ref26] and Green et al.[@ref27] These authors used the same database but reported incidence for different time periods.

Trends of diabetes incidence
----------------------------

Among the 47 studies, 16 provided information on incidence by age group. Of these 16 studies, 14 were plotted in [figure 2](#f2){ref-type="fig"}, with those from high incidence countries plotted in supplementary figure 1. In these figures, incidence in most studies increased progressively until the mid-2000s in all age groups. Thereafter, most studies showed a stable or decreasing trend, apart from studies in Denmark[@ref26] [@ref27] and Germany[@ref31] and in a US health insurance population[@ref9] where the incidence inflected upwards in the later years for some age groups.

![Incidence of diabetes over time for populations aged under 40, 40-54, 55-69, and 70 or more, among studies reporting age specific data. Only populations with at least three points were plotted. NHIS=National Health Interview Survey](magd049257.f2){#f2}

Using the first approach to analyse trends of diabetes incidence over time, we separated the data into populations based on sex and ethnicity, and allocated a time period to each population, generating 105 populations for analysis. Seventy four and 31 populations were predominantly Europid and non-Europid, respectively. [Table 2](#tbl2){ref-type="table"} and [table 3](#tbl3){ref-type="table"} show the reported trend for each population. [Table 4](#tbl4){ref-type="table"} summarises the findings in [table 2](#tbl2){ref-type="table"} and [table 3](#tbl3){ref-type="table"}, and shows that the proportion of populations reporting increasing trends peaked in 1990-99 and fell progressively in the two later time periods. Between 1960 and 1989, 36% (8/22) of the populations studied had increasing trends in incidence of diabetes, 55% (12/22) had stable trends, and 9% (2/22) had decreasing trends. In 1990-2005, diabetes incidence increased in 66% (33/50) of populations, was stable in 32% (16/50), and decreased in 2% (1/50). In 2006-14, increasing trends were reported in 33% (11/33) of populations, whereas 30% (10/33) and 36% (12/33) had stable or declining incidence, respectively.

###### 

Summary of patterns of diabetes incidence trends based on analyses reported in publications in 2000-14

  First author, year                        Years reported (range)   Mid-point   Country            Predominant ethnicity            Incidence trends (increasing, stable, or decreasing)              
  ----------------------------------------- ------------------------ ----------- ------------------ -------------------------------- ------------------------------------------------------ ---------- ----------
  **2000-05**                                                                                                                                                                                          
  Lipscombe et al 2007[@ref23]              1997-2003                2000        Canada             Europid                                                                                            Increase
  Ringborg et al 2008[@ref45]               1996-2003                2000        Sweden             Europid                                                                                            Stable
  Abraham et al 2015[@ref7]                 1990-2009                2000        US                 Europid                                                                                            Stable
  Oster et al 2011[@ref12]                  1995-2007                2001        Canada             Europid                          Increase                                               Increase   
  Oster et al 2011[@ref12]                  1995-2007                2001        Canada             Non-Europid (indigenous)         Increase                                               Stable     
  CDC et al 2008[@ref53]                    1995-2007                2001        US                 Europid                                                                                            Increase
  Liu et al 2007[@ref25]                    1999-2005                2002        China              Non-Europid (China)                                                                                Increase
  Monesi et al 2011[@ref35]                 2000-07                  2004        Italy              Europid                                                                                            Stable
  Lin et al 2013[@ref47]                    2000-07                  2004        Taiwan             Non-Europid (Taiwan)             Stable                                                 Stable     
  CCDSS et al 2017[@ref19]                  2000-06                  2004        Canada             Europid                          Increase                                               Increase   
  Cartensen et al 2008\*[@ref26] [@ref27]   2004-06                  2005        Denmark            Europid                                                                                            Increase
  Holden et al 2013\*[@ref49]               2001-10                  2005        UK                 Europid                          Increase                                               Increase   
  Tabaei et al 2012[@ref57]                 2002-08                  2005        US                 Europid                                                                                            Stable
  **2006-14**                                                                                                                                                                                          
  Song et al 2016[@ref36]                   2004-09                  2007        Korea              Non-Europid (Korea)                                                                                Decrease
  Karpati et al 2014[@ref34]                2004-12                  2008        Israel             Europid                                                                                            Decrease
  CCDSS et al 2017[@ref19]                  2007-11                  2009        Canada             Europid                          Stable                                                 Stable     
  Boehme et al 2015[@ref31]                 2008-10                  2009        Germany            Europid                          Increase                                               Increase   
  Strom et al 2014[@ref39]                  2006-11                  2009        Norway             Europid                          Stable                                                 Decrease   
  de Sousa-Uva et al 2016[@ref11]           2004-15                  2009        Portugal           Europid                          Increase                                               Increase   
  Read et al 2016[@ref41]                   2004-13                  2009        Scotland           Europid                          Stable                                                 Stable     
  Huber et al 2014[@ref46]                  2007-11                  2009        Switzerland        Europid                          Decrease                                               Decrease   
  Zghebi et al 2017\*[@ref50]               2004-14                  2009        UK                 Europid                          Stable                                                 Stable     
  Nichols et al 2015[@ref56]                2006-11                  2009        US                 Europid (Non-Hispanic white)     Stable                                                 Stable     
  Nichols et al 2015[@ref56]                2006-11                  2009        US                 Non-Europid (black)                                                                                Increase
  Nichols et al 2015[@ref56]                2006-11                  2009        US                 Non-Europid (Hispanic)                                                                             Increase
  Nichols et al 2015[@ref56]                2006-11                  2009        US                 Non-Europid (Asian)                                                                                Increase
  Nichols et al 2015[@ref56]                2006-11                  2009        US                 Non-Europid (Native American)                                                                      Increase
  Nichols et al 2015[@ref56]                2006-11                  2009        US                 Non-Europid (Hawaiian/Pacific)                                                                     Increase
  Green et al 2015\*[@ref27]                2007-11                  2009        Denmark            Europid                          Increase                                               Increase   
  Jansson et al 2015[@ref43]                2006-13                  2010        Sweden             Europid                          Decrease                                               Decrease   
  Geiss et al 2014[@ref6]                   2008-12                  2010        US                 Europid                          Decrease                                               Decrease   
  Weng et al 2106[@ref9]                    2007-12                  2010        US                 Europid                                                                                            Decrease
  Quan et al 2017[@ref32]                   2007-14                  2011        Hong Kong, China   Non-Europid (Hong Kong)          Decrease                                               Decrease   
  Song et al 2016[@ref36]                   2009-12                  2011        Korea              Non-Europid (Korea)                                                                                Stable

Empty cells imply that the study did not report data through that decade. CDC=US Centre for Disease Control and Prevention; CCDSS=Canadian chronic disease surveillance system (published online only).

These authors used the same country specific database but reported incidence for different time periods.

###### 

Summary of incidence trends over time of total or type 2 diabetes

  Study years   No of populations   Distribution of populations (No (%))             
  ------------- ------------------- -------------------------------------- --------- ---------
  1960-79       9                   4 (44)                                 5 (56)    0
  1980-89       13                  4 (31)                                 7 (54)    2 (15)
  1990-99       32                  22 (69)                                9 (28)    1 (3)
  2000-05       18                  11 (61)                                7 (39)    0
  2006-14       33                  11 (33)                                10 (30)   12 (36)
  Total         105                 ---                                    ---       ---

Populations that reported a decrease in incidence after 2005 came from the US,[@ref6] [@ref9] Israel,[@ref34] Switzerland,[@ref46] Hong Kong,[@ref32] Sweden,[@ref43] and Korea.[@ref36] Populations reporting increasing incidence after 2005 included Portugal,[@ref11] Denmark,[@ref26] [@ref27] and Germany,[@ref31] while populations from Canada,[@ref19] Italy,[@ref35] Scotland,[@ref40] Norway,[@ref39] US (non-Hispanic white),[@ref56] and the United Kingdom[@ref50] showed stable incidence. For two studies (16 populations),[@ref16] [@ref29] we could not determine a direction of a trend (increasing, decreasing, or stable), because they showed three phases of change with the trend of the middle phase differing from the trend of the first and last phase. Across the total time period, we observed a higher proportion of populations reporting stable or decreasing trends in predominantly Europid than in non-Europid populations (52% *v* 41%).

Using the second approach to analyse trends of diabetes incidence over time, we modelled 21 studies (62 populations) that reported diabetes counts and denominators specifically within each time period ([table 5](#tbl5){ref-type="table"}). The percentage of populations with a decreased or stable incidence was highest in 1980-89 (88%; 7/8), but this proportion was based on only eight populations in three studies. From 1990 onwards, the percentage with decreasing or stable incidence increased progressively, reaching 83% (19/23) of populations in 2006-14. Eight studies (21 populations) that were analysed by Joinpoint had no data on counts or denominators (supplementary table 3). When these data were considered with the data in [table 5](#tbl5){ref-type="table"}, the percentage of populations in 2006-14 with decreasing or stable incidence fell to 70% (19/27), but this proportion was still the highest of all the time periods, whereas the percentage for 1990-99 remained the lowest at 31% (5/16).

###### 

Annual percentage change in diabetes incidence in men (M), women (W), or total population (T) among studies that provided counts and denominators, by time period

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author, year                                                                                                Population   Country\           Annual percentage change (%) in incidence, P value                                                    
  ----------------------------------------------------------------------------------------------------------- ------------ ------------------ ---------------------------------------------------- --------------- --------------- ---------------- ----------------
  CCDSS et al 2017[@ref19] Canada                                                                             M            Canada             ---                                                  ---             ---             0.8, 0.001       −2.6, 0.001

  CCDSS et al 2017[@ref19] Canada                                                                             F            Canada             ---                                                  ---             ---             1.8, \<0.001     −2.8, \<0.001

  Dyck et al 2010[@ref16] (First Nation)                                                                      M            Canada             ---                                                  2.2, 0.06       4.8, \<0.001    −0.3, 0.86       ---

  Dyck et al 2010[@ref16] (First Nation)                                                                      F            Canada             ---                                                  −2.4, 0.02      −0.1, 0.90      −6.03, \<0.001   ---

  Dyck et al 2010[@ref16] (Non-First Nation)                                                                  M            Canada             ---                                                  −1.5, \<0.001   3.6, \<0.001    −1.4, 0.006      ---

  Dyck et al 2010[@ref16] (Non-First Nation)                                                                  F            Canada             ---                                                  −2.5, \<0.001   3.1, \<0.001    −1.0, 0.06       ---

  Horn et al 2007[@ref24]                                                                                     M            Canada             ---                                                  ---             −7.5, 0.08      ---              ---

  Horn et al 2007[@ref24]                                                                                     F            Canada             ---                                                  ---             −7.5, 0.01      ---              ---

  Liu et al 2007[@ref25]                                                                                      T            China                                                                                                   11.0, \<0.001    

  Boehme et al 2015[@ref31]                                                                                   M            Germany            ---                                                  ---             ---             ---              1.6, \<0.001

  Boehme et al 2015[@ref31]                                                                                   F            Germany            ---                                                  ---             ---             ---              2.9, \<0.001

  Quan et al 2017[@ref32]                                                                                     M            Hong Kong, China   ---                                                  ---             ---             ---              −1.70, \<0.001

  Quan et al 2017[@ref32]                                                                                     F            Hong Kong, China   ---                                                  ---             ---             ---              −1.27, \<0.001

  Karpati et al 2014[@ref34]                                                                                  T            Israel             ---                                                  ---             ---             −5.3, \<0.001    −3.2, \<0.001

  Song et al 2016[@ref36]                                                                                     M            Korea              ---                                                  ---             ---             11.3, \<0.001    1.3, \<0.001

  Song et al 2016[@ref36]                                                                                     F            Korea              ---                                                  ---             ---             17.2, \<0.001    −0.9, \<0.001

  Strom et al 2014[@ref39]                                                                                    M            Norway             ---                                                  ---             ---             ---              −0.5, 0.7

  Strom et al 2014[@ref39]                                                                                    F            Norway             ---                                                  ---             ---             ---              −1.5, 0.1

  Read et al 2016[@ref41]                                                                                     M            Scotland           ---                                                  ---             ---             −5.5, \<0.001    −0.03, 0.86

  Read et al 2016[@ref41]                                                                                     F            Scotland           ---                                                  ---             ---             −9.2, \<0.001    −0.8, \<0.001

  Jansson et al 2015[@ref43]                                                                                  M            Sweden             ---                                                  ---             ---             ---              −0.3, \<0.001

  Jansson et al 2015[@ref43]                                                                                  F            Sweden             ---                                                  ---             ---             ---              −0.9, \<0.001

  Ringborg et al 2008[@ref45]                                                                                 T            Sweden             ---                                                  ---             −3.8, 0.01      −4.8, 0.001      ---

  Huber et al 2014[@ref46]                                                                                    M            Switzerland        ---                                                  ---             ---             ---              −3.6, 0.001

  Huber et al 2004[@ref46]                                                                                    F            Switzerland        ---                                                  ---             ---             ---              −3.5, 0.02

  Lin et al 2013[@ref47]                                                                                      T            Taiwan             ---                                                  ---             ---             −2.4, \<0.001    3.9, \<0.001

  Tseng et al 2006[@ref48]                                                                                    M            Taiwan             ---                                                  ---             15.4, \<0.001   ---              ---

  Tseng et al 2006[@ref48]                                                                                    F            Taiwan             ---                                                  ---             8.1, \<0.001    ---              ---

  Zghebi et al 2017[@ref50]                                                                                   M            UK                 ---                                                  ---             ---             ---              −4.1, 0.01

  Zghebi et al 2017[@ref50]                                                                                   F            UK                 ---                                                  ---             ---             ---              −3.0, \<0.001

  Burke et al 2002[@ref52]                                                                                    M            US                 5.0, 0.04                                            5.0, 0.02       ---             ---              ---

  Burke et al 2002[@ref52]                                                                                    F            US                 −5.3, \<0.02                                         2.2, 0.29       ---             ---              ---

  McBean et al 2004[@ref54]                                                                                   T            US                 ---                                                  ---             5.0 \<0.001     ---              ---

  Nichols et al 2015[@ref56]                                                                                  T            US                 ---                                                  ---             ---             ---              −0.04, 0.91

  Geiss et al 2014\*[@ref6]                                                                                   M            US                 ---                                                  0.5, 0.81       13.6, \<0.001   1.6, 0.5         −4.1, \<0.001

  Geiss et al 2014\*[@ref6]                                                                                   F            US                 ---                                                  1.8, 0.32       9.4, \<0.001    4.7, 0.01        −1.5, 0.07

  Weng et al 2016[@ref9]                                                                                      T            US                 ---                                                  ---             ---             −8.0, \<0.001    ---

  Summary: Percentage (%) of populations that showed increasing incidence trends over time period             ---          ---                50                                                   12              66              31               17

  Summary: Percentage (%) of populations that showed decreasing or stable incidence trends over time period   ---          ---                50                                                   88              33              69               83
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

CCDSS=Canadian chronic disease surveillance system (published online only).

These data were supplemented using additional National Health Interview Survey data held by the US Centers for Disease Control and Prevention.

In a sensitivity analysis, we tested whether our selection of time periods was driving our results. When we defined the final time periods to be 2000-07 and 2008-14, our results were not altered, with 66% (21/32) of the populations in the last time period showing decreasing or stable trends. We also repeated the analysis in [table 4](#tbl4){ref-type="table"} and excluded cohort studies and surveys, and found that the results were not materially altered, with 65% (20/31) of populations in the last time period (from 2006 onwards) showing decreasing or stable incidence of diabetes.

Quality of studies
------------------

The median score for study quality was 10 (interquartile range 8-11; supplementary table 4). We repeated the analyses reported in [table 4](#tbl4){ref-type="table"} after excluding studies that had quality scores in the lowest quarter, and observed similar results to the main findings. For example, in 1960-89, 67% (10/15) of populations reported stable or decreasing incidence, while in the final time period, 67% (18/27) of populations reported stable or decreasing incidence of diagnosed diabetes.

Discussion
==========

Principal findings
------------------

In this systematic review of population based studies on diabetes incidence, we show evidence that the incidence of diagnosed diabetes increased in most populations from the 1960s to the early 2000s, after which a pattern emerged of levelling trends in 30% and declining trends in 36% of the reported populations. Although the lack of data for non-Europid populations leaves global trends in incidence unclear, these findings suggest that trends in the diabetes epidemic in some high income countries have turned in a more encouraging direction compared with previous decades. It is important to note that these results apply predominantly to type 2 diabetes, as even though many studies did not accurately define diabetes type, the incidence of type 2 diabetes in adults is an order of magnitude greater than that of type 1 diabetes.

The countries that showed stable or decreasing trends in the last time period were from Europe and east Asia, with no obvious clustering or commonalities. For the countries showing decreasing or stable diabetes trends, if the prevalence data were used to understand the diabetes epidemic in that country, a different message would be obtained. For example, national data from Korea showed that the prevalence of diabetes increased from 2000 to 2010.[@ref59] Similarly in Sweden, the prevalence of pharmacologically treated diabetes increased moderately from 2006 to 2014.[@ref43] In the US, the prevalence of diabetes reached a plateau when incidence began to decrease. However, we lacked incidence data from many areas of the world where the most steady and substantial increases in prevalence have been reported, including the Pacific Islands, Middle East, and south Asia. Large increases in incidence could still be occurring in these areas. The lack of incidence data for much of the world, combined with the common observation of discordance between incidence and prevalence rates where such data exist, both underscore the importance of using incidence data to understand the direction of the diabetes epidemic.

Incidence could be starting to fall for several reasons. Firstly, we might be starting to benefit from prevention activities of type 2 diabetes, including increased awareness, education, and risk factor modification. These activities have involved both targeted prevention among high risk individuals, similar to that conducted in the Diabetes Prevention study[@ref60] and Diabetes Prevention Programme[@ref61] [@ref62] in many countries,[@ref63] and less intensive interventions with broader reach such as telephone counselling in the general community.[@ref64] [@ref65] [@ref67] Secondly, health awareness and education programmes have also been implemented in schools and work places, and many changes to the physical environment, such as the introduction of bike tracks and exercise parks, have occurred.[@ref68] Thirdly, favourable trends in selected risk factors of type 2 diabetes in some countries provide indirect evidence of positive changes to reduce diabetes incidence. Finally, in the US, there is some evidence in recent years of improved diets and related behaviours, which include reductions in intake of sugar sweetened beverages[@ref69] and fat,[@ref70] small declines in overall energy intake, and declines in some food purchases.[@ref8] [@ref71]

Similar reduction in consumptions of sugar sweetened beverages have occurred in Norway[@ref72] and Australia[@ref73] and fast food intake has decreased in Korea.[@ref74] Some of these changes could be linked to a fall in diabetes incidence. Some places such as Scotland[@ref75] have also had a plateauing of obesity prevalence, but this is not universal. In the US, despite earlier studies suggesting that the rate of increase in obesity might be slowing down,[@ref76] [@ref77] more recent data show a small increase.[@ref78] [@ref79] While some evidence supports the hypothesis that these prevention activities for type 2 diabetes and an improved environment could trigger sufficient behaviour change to have an effect on diabetes incidence, other data, such as the continuing rising obesity prevalence in the US,[@ref79] casts some doubt over the explanations underpinning our findings on diabetes incidence trends.

Other factors might have also influenced reported diabetes incidence. Only 11% (n=5) of the studies reported here screened for undiagnosed diabetes, and therefore trends could have been influenced by secular changes in diagnostic behaviour. In 1997, the threshold for fasting plasma glucose for diagnosis of diabetes was reduced from 7.8 to 7.0 mmol/L, which could increase diagnosis of new cases of type 2 diabetes. In 2009-10, HbA1c was then introduced as an alternative way to diagnose diabetes.[@ref80] Evidence from some studies suggests that the HbA1c diagnostic threshold detects fewer people with diabetes than do the thresholds for fasting plasma blood glucose,[@ref80] [@ref81] potentially leading to a lowering of incidence estimates. However, across multiple studies, prevalence estimates based on fasting plasma glucose only versus HbA1c definitions are similar.[@ref82] Furthermore, because HbA1c can be measured in the non-fasting state (unlike the fasting blood glucose or oral glucose tolerance test), the number of people who actually undergo diagnostic testing could be higher with HbA1c. Nichols and colleagues[@ref56] reported that among seven million insured US adults, despite a shift towards HbA1c as the diagnostic test in 2010, the incidence of diabetes did not change from 2010 to 2011.

Another potential explanation for declining or stable diabetes incidence after the mid-2000s is a reduction in the pool of undiagnosed diabetes[@ref83] through the intensification of diagnostic and screening activities[@ref83] [@ref84] and changing diagnostic criteria during the previous decade.[@ref80] Data from Read and colleagues provide some evidence to support this notion.[@ref41]

Among the included studies, two studies specifically examined clinical screening patterns in parallel with incidence trends. These studies reported that the proportion of the population screened for diabetes increased over time, and the incidence of diabetes remained stable[@ref56] or fell.[@ref34] While the Karpati study[@ref34] combined data for glucose testing with HbA1c testing, the study by Nichols and colleagues[@ref56] separated the two, and showed that both glucose testing and HbA1c testing increased over time. A third study, in Korea,[@ref36] also noted that the incidence of diabetes decreased in the setting of an increase in the uptake of the national health screening programme. Despite the introduction of HbA1c for diagnosis of diabetes by the World Health Organization, this practice has not been adopted everywhere. For example, neither Scotland nor Hong Kong have introduced the use of HbA1c for screening or diagnosis of diabetes, and studies in these areas showed a levelling of diabetes incidence trends and decreasing trends, respectively.

Our findings appear to contrast with data showing increasing global prevalence of diabetes.[@ref1] [@ref3] However, increasing prevalence could be influenced by improved survival of people with diabetes, because this increases the length of time that each individual remains within the diabetes population. As is shown in several studies in this review,[@ref23] [@ref41] mortality from diabetes and incidence of diabetes might both be falling but as long as mortality is lower than incidence, prevalence will rise. Therefore, we argue that prevalence alone is an insufficient measure to track the epidemic of diabetes and other non-communicable diseases.

Strengths and weaknesses of this study
--------------------------------------

A key strength of this work was the systematic approach and robust methodology to describe trends in diagnosed diabetes incidence. We also presented the reported trends allocated to approximate time periods, as well as conducting our own regression within exact time periods. The following limitations should also be considered. Firstly, we did not formally search the grey literature, because a preliminary grey literature search revealed only low quality studies, with inadequate methodological detail to provide confidence in any observed incidence trends, and thus review could be subject to publication bias. Secondly, we were not able to source age or sex specific data on all populations. Thirdly, it was not possible to adjust for different methods of diabetes diagnosis or ascertain trends by different definitions of diabetes. Fourthly, most data sources reported only on clinically diagnosed diabetes and so were subject to influence from diagnostic behaviour and coding practices. Fifthly, study type changed over time, with large administrative datasets becoming more common and cohort studies becoming less common over time. Nevertheless, the size and absence of volunteer bias in administrative datasets likely make them less biased. Finally, data were limited in low and middle income countries.

Conclusions and unanswered questions
------------------------------------

This systematic review shows that in most countries for which data are available, the incidence of diagnosed diabetes was rising from the 1990s to the mid-2000s, but has been stable or falling since. Preventive strategies and public health education and awareness campaigns could have contributed to this recent trend. Data are limited in low and middle income countries where trends in diabetes incidence might be different. Improvement of the collection, availability, and analysis of incidence data will be important to effectively monitor the epidemic and guide prevention efforts into the future.

### What is already known on this topic

1.  Monitoring of the diabetes epidemic has mainly focused on reporting diabetes prevalence, which continues to rise; however, increasing prevalence is partly driven by improved medical treatment and declining mortality

2.  Studies on diabetes incidence are scarce, but among those that exist, some report a fall or stabilisation of diabetes incidence;

3.  Whether the proportion of studies reporting falling incidence has changed over time is not known

### What this study adds

1.  This systematic review of published data reporting diabetes incidence trends over time shows that in most countries with available data, incidence of diabetes (mainly diagnosed diabetes) increased from the 1990s to the mid-2000s, and has been stable or falling since

2.  Preventive strategies and public health education and awareness campaigns could have contributed to this flattening of rates, suggesting that worldwide efforts to curb the diabetes epidemic over the past decade might have been effective

3.  Published data were very limited in low and middle income countries, where trends in diabetes incidence might be different

The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the US Centers for Disease Control and Prevention (CDC).
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